tiprankstipranks
Trending News
More News >
Valerio Therapeutics (FR:ALVIO)
:ALVIO
France Market

Valerio Therapeutics (ALVIO) Financial Statements

Compare
0 Followers

Valerio Therapeutics Financial Overview

Valerio Therapeutics's market cap is currently €10.17M. The company's EPS TTM is €-0.123; its P/E ratio is ―; Valerio Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 1.80M€ 1.44M€ 4.06M€ 1.78M€ 4.29M
Gross Profit€ 1.27M€ 929.00K€ 3.69M€ -166.00K€ 3.94M
Operating Income€ -20.29M€ -17.11M€ -5.58M€ -7.81M€ -9.79M
EBITDA€ -18.44M€ -17.04M€ -4.90M€ 2.33M€ -35.66M
Net Income€ -20.34M€ -19.56M€ -5.94M€ 1.09M€ -33.73M
Balance Sheet
Cash & Short-Term Investments€ 6.82M€ 14.59M€ 17.89M€ 14.52M€ 5.71M
Total Assets€ 35.27M€ 43.09M€ 53.06M€ 46.51M€ 37.63M
Total Debt€ 9.00M€ 10.09M€ 14.76M€ 6.26M€ 8.28M
Net Debt€ 2.18M€ -4.50M€ -3.12M€ -8.27M€ 2.57M
Total Liabilities€ 20.47M€ 20.82M€ 20.12M€ 17.47M€ 20.43M
Stockholders' Equity€ 14.80M€ 22.27M€ 32.94M€ 29.04M€ 17.20M
Cash Flow
Free Cash Flow€ -18.78M€ -9.93M€ -8.71M€ -4.80M€ -7.72M
Operating Cash Flow€ -18.60M€ -9.44M€ -8.57M€ -4.68M€ -7.70M
Investing Cash Flow€ -177.00K€ -409.00K€ -66.00K€ 6.01M€ 137.00K
Financing Cash Flow€ 10.76M€ 6.46M€ 11.98M€ 7.48M€ 2.01M
Currency in EUR

Valerio Therapeutics Earnings and Revenue History

Valerio Therapeutics Debt to Assets

Valerio Therapeutics Cash Flow

Valerio Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis